Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Wi
Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Wi
复制标题
基于生理学的药代动力学-药效学模型，表征 CYP2C19 多态性，以预测患有或患有冠状动脉疾病的患者口服氯吡格雷后的药代动力学及其抗血小板聚集作用
作者：
Xu RJ;Kong WM;An XF;Zou JJ;Liu L;Liu XD
